In this work, the development and applications of a fluorescence detection system using optical parametric oscillator (OPO) laser excitation for in vivo disease diagnosis including oral carcinoma are described. The optical diagnosis system was based on an OPO laser for multi-wavelength excitation and time-resolved detection. The pulsed Nd-YAG-pumped OPO laser system (6 ns, 20 Hz) is compact and has a rapid, broad, and uniform tuning range.
Introduction
The development of methods to effectively diagnose premalignant and early invasive cancers is extremely important for improving chances of survival. Numerous diagnostic strategies using novel bioreceptor-based probes and tumor markers have been investigated to accomplish this goal (1-3). However, various approaches are still being attempted, and sensitivity and selectivity for cancer diagnosis need to be improved. Native cellular fluorescence, which utilizes innate capacities of tissues to absorb and transmit light for distinguishing the difference between normal and neoplastic tissue, has gained increasing attention due to its high sensitivity and specificity. An advantage of monitoring native cellular fluorescence is that it precludes the exogenous drugs that may cause side effects in humans. Numerous intracellular fluorescent components capable of emitting light of specified wavelengths have been used as biomarkers to distinguish normal from neoplastic tissue. A large number of proteins, coenzymes, and micronutrients are included in these biomarkers. Laser-induced fluorescence (LIF) is a very sensitive technique. Indeed, a single-molecule detection has been demonstrated with LIF. The native cellular fluorescence technique based on LIF has led to direct in vivo cancer diagnosis owing to its sensitivity. Advantages of this optical diagnostic procedure are that it is rapid and highly sensitive. Eventually, it may eliminate the need for invasive and sometimes traumatic biopsies. Numerous investigations have shown that the optical diagnostic technique is a useful tool to screen diseases of the lung, cervix, esophagus, and colon (4) (5) (6) (7) (8) (9) . Various lasers such as helium cadmium and pulsed nitrogen have been used as excitation sources and fluorescence emission regions of the 380-680 nm have been analyzed to observe abnormalities of neoplastic tissues.
The wavelengths for excitation and emission need to be optimized for different organs and disease stages because compositions of biomarkers in the neoplastic tissue may be different for different conditions. It has been reported that the use of multiple excitation and emission profiles may lead to more accurate diagnosis of disease state of a given tissue (10) . Until now, most excitation sources for the optical diagnostic system have been lasers with outputs of a single wavelength, such as pulse nitrogen or helium cadmium lasers. Although dye laser systems are capable of providing a larger excitation wavelength range, a laborious change of laser dyes often needs to be performed since a laser dye system usually covers only 20-30 nm. Also, the wavelength range and intensity distribution in dye laser systems are typically too narrow and nonuniform for optical diagnoses. As an alternative, a tunable laser system using an optical parametric oscillator (OPO) crystal, which permits a much broad range of excitation wavelengths, is a very attractive excitation source for in vivo cancer diagnosis. In this report, the application of a compact tunable OPO laser system to in vivo optical diagnosis is demonstrated. As an improvement over the conventional laser-pumped OPO's (11, 12), this laser system was designed so that the OPO crystal and the Nd-YAG laser are combined in a single portable unit. The benefit from this OPO laser system is rapid, easy, uniform, and broad wavelength tuning from 400 to 1100 nm. More specifically, the broad tunability and uniform intensity distribution of laser emission may contribute significantly to more specific characterization of neoplastic tissues.
Photodynamic therapy (PDT) is a newly emerging therapy in the areas of cancer, age related macular degeneration, and psoriasis (13, 14) . The unique property of PDT drugs is its preferential accumulation in neoplastic tissues. Once PDT drugs are injected into animals or humans, excitation radiation with a wavelength appropriate for a given drug and disease is delivered through the illuminating device and irradiates the tissues. The PDT drug then absorbs the light and is promoted to an excited state which is extremely active. The excited PDT drug interacts with molecular oxygen to produce highly reactive and cytotoxic "singlet" oxygen. As a result, the direct tumorocidal activity and micro vascular damage destroys tumor cells. PDT drugs can also be used for photodetection of cancer based on its selective accumulation in neoplastic tissues. PDT is currently in use (lung, esophageal, gastric, gall bladder, cervical and bladder cancer) or is under investigation for both oncology and non-oncological areas of medicine and surgery in various countries throughout the world. In order to optimize PDT and photodetection of cancer, the uptake of the dye and the dye contrast between normal and neoplastic tissue are the most important factors to be considered. Knowledge of the time-dependent contrast of the LIF signal after intravenous injection between a tumor and the surrounding normal tissue is a main concern.
In this report, applications of the compact OPO tunable laser unit with time-gated detection to in vivo animal measurements are investigated. In general, for each type of tissue, optical excitation and emission wavelengths should be optimized before in vivo measurement is performed. Thus, those parameters are first optimized with ex vivo samples. However, in vitro optimal conditions are not necessarily consistent with in vivo environments due to differences in parameters such as blood flow and biochemical pathways. Based on this fact, an optical diagnosis system that allows rapid in vivo optimizations such as the one described herein is expected to improve in vivo studies such as disease diagnoses. The optical system introduced in this work, which permits rapid scanning of excitation wavelengths, was applied to in vivo photodetection measurements, including autofluorescence of the esophagus, stomach, and small intestine in canine animal, and PDT-drug based detection of human xenograft of oral carcinoma in mice.
Materials and Methods

Materials
Polystyrene microspheres were purchased from Polysciences, Inc.(Warrington, PA). 5-aminolevulinic acid and protoporphyrin IX were obtained from Sigma-Aldrich.
OPO Laser System:
The OPO laser (OPOTEK, Carlsbad, CA) was an integrated tunable laser system where the third harmonic beam (355 nm) of an Nd:YAG laser is used to pump an Optical Parametric Oscillator (OPO). Compared to the conventional coupling of a Nd:YAG laser with an OPO, this laser system integrates a Q-switched Nd:YAG laser, harmonic module(s), an OPO, steering and wavelength separation optics, and control electronics combined in a single compact unit with a physical dimension of 6.5" (width) × 15.5" (length) × 5.5" (height). The OPO is passive and nonlinear optical device that converts the third harmonic beam of the Nd:YAG laser into two beams. The main beam, designated as the "signal", is more powerful compared to the other beam, designated as the "idler". The output wavelength of the OPO laser can be obtained by the equation. n pump /λ pump = n signal /λ signal + n idler /λ idler where n x is the refractive index of the identical material at the given wavelength, the range of λ signal is 400 nm to 700 nm, and the range of λ idler is 700 nm to 1100 nm. The "signal" or the "idler" beams can be selected by the position of a shutter placed in the path of OPO laser beam. The wavelength tuning is achieved by rotating the OPO crystal with respect to the propagation of the third harmonic beam. This operation is controlled by commercial software that enables a tuning time of 1 to 2 second. The repetition rate and the duration time of the OPO laser pulse were 20 Hz and 6 ns, respectively.
Triggering and Gating of Instruments
The intensified charge-coupled device (ICCD) (Andor Technology, South Windsor, CT) was externally triggered by the OPO laser's internal trigger. The ICCD was controlled by a labtop PCIcompatible computer equipped with a controller card. The OPO laser's synchronous trigger output was connected to the external trigger input of the Multi Input/Output (I/O) Box (Andor Technology, South Windsor, CT) controlled via the controller card. The delay generator trigger output of the Multi I/O Box was connected to the external trigger socket of the Stanford Research Systems (SRS) delay generator, which was controlled via a connection from the computer. The output of the SRS delay generator was connected to the Gate Input on the ICCD detector head. The gate parameters such as delay and width were set with the ICCD controller software and sent to SRS delay generator.
Optical System for In Vivo Measurements of Organs in Canine Animal
As shown in Figure 1 , the tunable integrated OPO laser was used for excitation of organs in canine animal. A bifurcated fiber bundle consisted of seven 200 µm diameter fibers for excitation and twelve 200 µm diameter fibers for emission. The laser beam was focused onto the bifurcated fiber using a lens in the OPO laser system and the excitation radiation was transmitted through the fiberoptic probe. This fiberoptic probe was positioned on the surface of tissues of esophagus, stomach, or small intestine through the biopsy channel of an endoscope. The fluorescence from tissues was collected by the fiberoptic probe and transmitted back through the detection bundle of the bifurcated bundle, the end of which was fixed in front of the entrance slit of a spectrometer (Acton Research Corporation, SpectraPro-150, Acton, MA) containing a grating of 150 groove/mm. The ICCD was attached at the exit slit of the spectrometer. The ICCD consisted of 256 × 1024 pixels and the physical dimension of one pixel of the ICCD was 13 × 13 µm. The ICCD was cooled to -10º C during operation. An Hg lamp was used to perform the spectral calibration of the ICCD, using the 435.8 nm, 546.1 nm, 577 nm, and 579 nm lines. It was found that the grating had a dispersion of 0.5 nm per pixel. After this wavelength calibration, the ICCD was operated in the full vertical binning mode.
Tumor Model in Mice
The mice studies were performed in accordance to the protocols approved by the Institutional Animal Care and Use Committee at Ohio State University and Oak Ridge National Laboratory. In this study we used three mice for evaluating the instrumental system. Male athymic BALB/c (nu/nu) mice weighing 18-22 g were purchased from Charles River Laboratories (Wilmington, MA). To generate a tumor xenograft, 10 6 KB human oral carcinoma cells were injected subcutaneously (s.c.) into a mouse using a 26-gauge needle in the upper chest area. The tumors reached palpable sizes of 10-20 mg in 14 days following tumor cell implantation and ~ 400 mg at the time of the study (28 days post inoculation). To induce pPIX production, 10 mmoles/kg body weight of 5aminolevulinic acid (5-ALA) was intraperitoneal (IP) injected in 100 µL of saline. Five minutes prior to spectral analyses and imaging, the mouse was anesthetized by IP injection of 100 mg/kg of ketamine and 10 mg/kg of xylazine dissolved in saline and secured on a board to allow easy visual access to the tumor. Additional IP injections of ketamine/xylazine were given as necessary to maintain unconsciousness of the mouse during the entire procedure. At the end of the study, the mouse was sacrificed via an overdose of the anesthetic. Fluorescence emissions were obtained using the fiberoptic which was placed at tumor and non-tumor areas at every one hour after the injection of 5-ALA into the mice.
Results and Discussion
Light transport in tissues that have several chromophores is dominated by scattering processes. Accordingly, understanding of light transport in tissues can provide information on scattering and absorption properties inherent to the physiological state of tissues. The scattering properties of tissues are dependent on tissue morphology while the absorption properties are related to chromophores such as nicotinamide adenine dinucleotide (NADH), melanin, hemoglobin, elastin, and riboflavin. It is expected that sizes and refractive indices of scatterers such as cells, organelles, and proteins can influence scattering in tissues. The light transport in tissues has been described based on a phenomenon called photon migration (15). Multiple scattering leads to photon migration, in which individual photons are thought to travel with a random walk along a wide variety of complex paths through the tissue. This photon migration phenomenon provides knowledge on spatial distribution of light inside a tissue, the understanding of which is for taking advantage of noninvasive fluorescence technique for in vivo cancer diagnosis. Artificial tissue-simulating phantoms have been designed to study how optical signals propa-gate in turbid biological tissues (16). Such phantoms are capable of providing theoretical predications about light propagation in biological tissues and testing biomedical optical instrumentation prior to clinical studies. In spite of studies on scattering in tissues, separation of scattering signal from that due to absorption has not been developed. However, recent in vivo optical diagnosis based on measurement of fluorescence has shown great capabilities to distinguish between normal and neoplastic tissues even without the separation of signals due to scattering and absorption. These results suggest a need to practically optimize experimental parameters to effectively extract signal due to absorption from that due to laser scattering in tissues for in vivo optical diagnosis. In this report, we used tissue phantoms based on polystyrene microspheres to test the newly constructed optical diagnosis system so that experimental conditions could be optimized to obtain the highest fluorescence signal with respect to laser scattering in tissue. Time-resolved LIF detection is a well-established technique to discriminate fluorescence signal against the laser scattering signal. In general, fluorescence emission occurs temporally in the range of nanoseconds compared to laser scattering which occurs in the range of picoseconds. Therefore, gated detection can permit discrimination of fluorescence emission from the laser scattering of laser excitation pulses. Time-gated LIF detection amplifies the signal only for an optimized gating period. This can potentially eliminate any unwanted signal produced outside the temporal range of fluorescence from biomarkers in tissues. The tissue phantoms consist of polystyrene microspheres and biomarkers such as riboflavin and hematoporphyrin. These biomarkers that exist in our human body are very appropriate as a model for investigating in vivo tissues. Of target fluorophores, protoporphyrin IX seems to have the longest lifetime of 7.4 ns as shown in Table I (17) . The newly constructed optical diagnosis system excites biomarkers that exist in tissues and collects their fluorescence. Accordingly, the gating parameters of the optical diagnosis system, applied to both in vivo measurements in canine animals and tumor detection in mice, was optimized to collect fluorescence from the biomarker with the longest fluorescence lifetime. With respect to a fluorescence lifetime τ, the percentage of the collected fluorescence signal varies as (1-e -∆t/τ ). For τ = 7.4 ns, it was calculated that fluorescence emission of 99.9% could be collected within 51 ns. Based on this calculation, the gate width of 51 ns was used throughout this work. The effect of a 10-to 15-ns period of detection beyond the temporal range of fluorescence is negligible. The optimal gate delay was determined to be 39 ns for the highest S/N. Larger gate delays provide smaller fluorescence intensity with smaller laser scattering while smaller gate delays provide larger fluorescence intensity with larger laser scattering.
Gastrointestinal malignancies are the second largest cause of cancer-related deaths in the world (18). The representative screening tools include standard white light endoscopy and frequent surveillance with biopsy. However, poor sensitivity inherent with white light endoscopy invokes a significant limitation. Optical diagnosis systems based on LIF, which are intended to replace biopsy with tissue excision, have been developed to further improve the sensitivity and selectivity. Optically based endoscopic techniques are capable of monitoring relative changes in the way light interacts with tissue along the diseases transformation pathway. The tissue consists of a complex of several biomarkers with different concentrations depending on depths in tissues. This leads to the varying fluorescence from biomarkers in the various layers at the luminal tissue. Usually, it is difficult to distinguish individual biomarkers in a given tissue spectrum due to spectral overlap of biomarkers. However, changes of intrinsic fluorescence spectra of tissue that occur during disease transformations reflects alteration of microenvironments in the tissue such as biochemical composition, tissue morphology, metabolic status of tissue, and light absorption and scattering properties. Although characterizations of individual biomarkers are difficult, this makes an optical diagnosis system useful tool in diseases diagnosis. It has been reported that the degree of change of in vivo fluorescence spectra is strongly dependent on excitation wavelength. This is because the dominant biomarkers excited in a tissue can be variable for different stages of disease, and are variable as a function of excitation wavelength, as shown in Table I . Also, the penetration depth of excitation light into the tissue increases with excitation wavelength. This suggests the need to use optimal excitation and emission wavelength in the characterization of neoplastic tissues. For in vivo fluorescence measurements, the optimal excitation and emission wavelengths can be approximated prior to the measurement through in vitro sample studies. However, the optimized condition obtained with in vitro sample study is not always consistent to in vivo environment where tissue surface morphology, hemoglobin absorption, and blood flow can provide different conditions compared to the in vitro environment. Based on these facts, our optical diagnosis system with a compact tunable OPO laser, which is capable of allowing rapid tuning of excitation wavelengths for the optimal in vivo condition, should prove to be a promising tool to meet above demands. Our optical diagnosis system was employed for in vivo measurements of autofluorescence in tissues of esophagus, stomach, and small intestine in a normal dog through an endoscope. It is impossible to excite all the tissue fluorophores at a single excitation wavelength. The shorter laser excitation wavelength region is capable of exciting more tissue fluorophores while longer laser excitation wavelength region allows exciting fewer tissue fluorophores. When a single laser excitation wavelength is used, it is desirable to choose a wavelength that produces subtle and important spectral features. The selection of a wavelength that permits the excitation of as many tissue fluorophores as possible is not always the best approach, because it does not necessarily provides important spectral information. The optical system herein that provides rapid tunning is very appropriate for selection of the wavelength to give the important spectral information. In addition, multispectral information by multiple excitations may lead to spectral features which can not be obtained using a single laser wavelength. Figure 2 shows the comparison of spectra from the tissue of dog small intestine when the endoscopic white light source used to illuminate the tissue is turned on and off. There is little difference between spectra indicating that the background signal from the CW "white" light was negligible. This result reflects the effectiveness of CW background signal via the optimized time-gated detection. The endoscopic "white" light illumination could therefore be used throughout all measurements to help observe tissue morphology. Figure 3 shows spectra obtained from the tissue of dog small intestine immediately before and after washing the small intestine with water. Surprisingly, the emission band with maximum inten-
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Technology sity at 640 nm could not be detected after the rinsing step. This result indicates that spectra were obtained from bile secretions deposited on the tissue of small intestine that can be washed away by water. We noticed that the bile secretion contained porphyrins, heme, and bilirubin (19). The bile secreted by the liver enters the upper small intestine by way of the bile duct. Bile has an important role in fat digestion as an emulsifier in the first stage of fat digestion. Of porphyrin intermediates, existence of coprophyrin, uroporphyrin, and protoporphyrin IX in the bile secretion has been reported (19). Protoporphyrin IX is predominant among porphyrins present in the bile secretion. Accordingly, it is believed that the fluorescence due to porphyrins in bile secretions was completely eliminated by the washing step. In order to confirm that the emission band at 640 nm corresponds to porphyrins, multispectral analyses using multiple excitations were performed in the small intestine. When the laser exci- tation wavelengths were scanned from 415 to 480 nm at 5 nm intervals, a prominent feature could be found in the spectra of the esophagus, stomach, and small intestine as shown in Figure 4 . The broad and intense emission close to the laser excitation wavelength is observed in all spectra. Spectra of esophagus, stomach, and small intestine excited at 415 nm showed almost the same pattern. In our previous report, we demonstrated the differential normalized fluorescence technique to distinguish normal and neoplastic tissues in esophagus based on spectral features in the 460 to 490 nm range using a single laser excitation wavelength (5). The malignant tissue showed much decreased intensity in this emission region. In this study, the similarities in tissue spectra for dog stomach, small intestine, and esophagus obtained at 415 nm demonstrate potential capability of the newly constructed optical system to be applied to cancer diagnosis of stomach and small intestine in addition to the esophagus. The interesting result of in vivo multispectral analyses using multiple excitations is illustrated by the spectra of dog small intestine excited at 420 to 440 nm, as shown in Figure 5 . When the tissue of small intestine is excited at 420 to 440 nm, a fluorescence band with maximum intensity at 640 nm is observed.
On the other hand, 640 nm band is not observed for other excitation wavelengths. This spectral feature can not be observed if only a single laser excitation wavelength is used. Clearly, the use of a tunable excitation source is therefore advantageous for optimizing diagnostic spectra features. Further, the optical system described herein could be very advantageous for in vivo spectral feature at 640 nm because the tunable source precluded the need for preliminary in vitro sample studies. Another interesting aspect of the above results is that the emission band at 640 nm could not be observed in esophagus and stomach tissues. This further supports that a biochemical product that is excreted only from small intestine, the bile, is responsible for the detection of protoporphyrin IX in small intestine. Another important feature of multispectral analysis based on tunable excitations is that it may permit identification of tissue fluorophores based on spectral properties such as its absorption and emission. The rapid and broad tunable OPO laser enables it effective to monitor the specific tissue autofluorescence. Of tissue fluorophores, protoporphyrin IX is one of the porphyrin intermediates produced during heme synthesis in erythrocytes that has a maximum absorption wavelength of 440 nm and a maximum emission wavelength of 635 nm (10). Recently, in colorectal cancers, red fluorescence was observed on excitation at 505 nm, mainly arising due to endogeneous biomarkers, protoporphyrin IX (20, 21) . Earlier studies revealed that protoporphyrin IX content increased in malignant lesions. In addition to the fluorescence emission band observed around 500 nm, red fluorescence exhibited in colorectal tissues can be exploited to enhance the sensitivity and specificity of LIF diagnosis of malignancy in the intestine. The effective approach to monitor specific tissue autofluorescence by using the specific excitation wavelength is an advantage that can be obtained by the rapid and broad tunable laser. Another interesting point that can be expressed from results in Figure 4 and 5 is the potential application of the newly introduced optical system to clinical diagnosis for the porphyria disease. The porphyrias are a family of inherited diseases associated with a partial defect in one of the other seven enzymes that activate heme biosynthesis (22). This defect leads to specific metabolic abnormalities reflected by diagnostic laboratory findings in the blood, urine, and stool from the affected individual. Of porphyrias, erythropoietic protoporphyria (EPP) is a disease of porphyrin metabolism characterized by abnormally elevated levels of protoporphyrin IX in erythocytes, feces and plasma, and by sensitivity to visible light (20). In EPP, a decreased amount of the enzyme ferrochelatase, which catalyses the insertion of ferrous iron into protoporphyrin IX, leads to the accumulation of protoporphyrin IX in reticulocytes. This excess protoporphyrin leaks rapidly into the plasma from the maturing reticulocytes and young erythrocytes. The protoporphyrin is then partially cleared from the plasma by the liver and excreted into the bile (with or without some recirculation via the enterohepatic circulation). Accumulation of this protoporphyrin in the liver may lead, in rare cases, to serious liver disease. It has been reported that patients with protoporphyria showed the expected increase in protoporphyrin in the bile (19). It is noteworthy that the increased amount of protoporphyrin IX due to protoporphyria can be monitored through the spectral band at 640 nm by the newly constructed optical diagnosis system. In general, the diagnosis of porphyrias is dependent on in vitro analysis using urine and blood. Results in Figure 4 and 5 show that in vivo diagnosis of porphyria can potentially be performed using the newly constructed optical diagnosis system, which can offer the advantage of monitoring real biochemical pathways related to a particular disease.
The other option for fluorescence diagnosis using the system described herein is to monitor in vivo exogenous fluorescent drugs such as PDT drugs. The main issue in the use of PDT drugs to clinical application can be selective localization in neoplastic tissues, where they enable site-specific therapy. Of PDT drugs, 5-aminolevulinic acid (5-ALA) has been shown to provide good fluorescence contrast between normal and neoplastic tissues. When 5-ALA is injected into patients, pro-toporphyrin IX is preferentially accumulated in neoplastic tissues. Deficiencies in iron or in ferrochelatase seem to be a main reason of the preferential accumulation (14). A significant advantage of 5-ALA-induced fluorescence is the strong fluorescence signal compared to the autofluorescence obtained from tissue fluorophores. This can lead to simpler instrumentation and may contribute to early detection of tumor. Figure 6 shows the comparison of protoporphyrin IX detection between normal and tumor tissue in a mouse. Human xenograft of oral carcinoma implanted into the mouse was tested. These spectra were obtained 2 hours after injection of 5-ALA into the mice. The tumor tissue obviously exhibits larger fluorescence intensity compared to normal tissue. After monitoring distribution of 5-ALA in tissues, the 5-ALA was photoactivated for localized therapy. Two hours after the injection of 5-ALA, the mouse was exposed to 488 nm radiation from an Ar-ion laser to activate the 5-ALA. The protoporphyrin IX intensity in the tumor tissue was then monitored as a function of time. As a result of the destruction of tumor cells, the fluorescence intensity in tumor tissue was observed to decrease with time, starting 3 hours after injection of 5-ALA. Furthermore, a distinctive reduction in size of tumor was observed. These results show successful monitoring of diagnosis and therapy of human oral carcinoma using 5-ALA by the newly introduced optical system.
Conclusion
In this work, an optical diagnosis system based on the compact OPO laser was developed and applied to in vivo fluorescence measurements. Autofluorescence in tissues of esophagus, stomach, and small intestine in canine animal and oral carcinoma in laboratory mice were investigated. Due to the rapid and broad tuning capability of the OPO laser, the newly constructed system demonstrated an advantage for monitoring in vivo spectral feature of porphyrin using multispectral analyses, which precluded the need for preliminary in vitro sample studies. The in vivo spectrum of porphyrin was obtained only in the small intestine. From the result obtained before and after washing the small intestine, it was concluded that the in vivo spectrum of porphyrin was produced by porphyrin-containing bile secretion. Also, the newly constructed system demonstrated the detection of human oral carcinoma xenografts in mice using 5-ALA PDT drug. Based on above results, the newly constructed system based on rapid, compact, and tunable OPO laser that provides multiwavelength spectral analyses, is expected to contribute to the in vivo disease diagnosis.
